期刊
CANCER AND METASTASIS REVIEWS
卷 41, 期 4, 页码 953-963出版社
SPRINGER
DOI: 10.1007/s10555-022-10065-z
关键词
Cancer; Nuclear envelope; Cancer therapeutics; Lamin; Lem-Domain protein; Banf1
类别
资金
- Centre for Genomics and Personalised Health Industry Partnership Grant
- Chenhall Research Award
This review provides an overview of the potential role and possible applications of inner nuclear membrane proteins in cancer therapeutics.
Despite significant advances in our understanding of tumourigenesis and cancer therapeutics, cancer continues to account for 30% of worldwide deaths. Therefore, there remains an unmet need for the development of cancer therapies to improve patient quality of life and survival outcomes. The inner nuclear membrane has an essential role in cell division, cell signalling, transcription, cell cycle progression, chromosome tethering, cell migration and mitosis. Furthermore, expression of several inner nuclear membrane proteins has been shown to be frequently altered in tumour cells, resulting in the dysregulation of cellular pathways to promote tumourigenesis. However, to date, minimal research has been conducted to investigate how targeting these dysregulated and variably expressed proteins may provide a novel avenue for cancer therapies. In this review, we present an overview of the involvement of the inner nuclear membrane proteins within the hallmarks of cancer and how they may be exploited as potent anti-cancer therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据